Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection

URL

https://academic.oup.com/jcem/article/106/3/e1343/5934827

Authors

Jose L. Hernandez, Daniel Nan, Marta Fernandez-Ayala, Mayte García-Unzueta, Miguel A. Hernández-Hernández, Marcos López-Hoyos, Pedro Muñoz-Cacho, José M. Olmos, Manuel Gutiérrez-Cuadra, Juan J. Ruiz-Cubillán, Javier Crespo, and Víctor M. Martínez-Taboada

Published Date

October 27, 2020

Publication

The Journal of Clinical Endocrinology & Metabolism (JCEM)

Organization

University of Cantabaria (Spain)

Key Excerpts

“Results: … Vitamin D deficiency was found in 82.2% of COVID-19 cases and 47.2% of the population-based controls… Vitamin D-deficient COVID-19 patients had a greater prevalence of hypertension and cardiovascular diseases, raised serum ferritin and troponin levels, as well as a longer length of hospital stay than those with serum 25OHD levels ≥20 ng/m.”

© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Medium

document

Topics

COVID-19,medical treatments,nutraceuticals,vitamin D